Forecasted · Cooperative Agreement
National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers
Centers for Disease Control - NCHHSTP, Department of Health and Human Services
Key facts
Copied from the official Grants.gov record. Last verified October 29, 2026.
- Program name
- National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers
- Issuing agency
- Centers for Disease Control - NCHHSTP (Department of Health and Human Services)
- Opportunity number
- CDC-RFA-PS-27-0011
- Funding type
- Cooperative Agreement
- Funding purpose
- Health
- Status
- Forecasted
- Application deadline
- Forecasted · estimated close June 1, 2027 (agency estimate)Agency note: Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
- Agency estimates
- Estimated posting: March 30, 2027. Estimated award date: August 31, 2027. Estimates can change.
- Published award range
- Not published by the agency
- Estimated total program funding
- $5,500,000
- Expected number of awards
- 2
- Cost sharing or match required
- No
- Eligible applicants (official categories)
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Relevant to
- Businesses and NonprofitsHow we determined this: Grants.gov eligibility includes small businesses or for-profit organizations. Grants.gov eligibility includes nonprofit organizations.
- Geographic restrictions
- None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.
- Assistance Listing (CFDA)
- 93.270
- Official source
- View on Grants.gov ↗
- Application URL
- www.grants.gov/search-results-detail/363142 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.
- Source identifier
- Grants.gov opportunity ID 363142 · Funding opportunity number CDC-RFA-PS-27-0011
- Posted
- July 9, 2026 · Source last updated July 10, 2026
- Last verified
- October 29, 2026 (against Grants.gov)
- Data completeness
- 83% of key fields published by the sourceNot published: published funding range, eligibility criteria text.
- Record confidence
- mediumforecast — dates and amounts are agency estimates.
Description (from the official listing)
In alignment with CDC's viral hepatitis strategic goals and current epidemiology, this Notice of Funding Opportunity (NOFO) will address the need for increasing awareness of viral hepatitis prevention, testing, and treatment options among populations disproportionately affected by hepatitis B and/or hepatitis C virus infections. The priority populations' needs will also be addressed by increasing healthcare professionals' competence in the evaluation and treatment of hepatitis B and/or hepatitis C virus infection. The outcomes of this NOFO will be achieved through two separate components. An organization may apply for one component or both components by submitting two separate applications, one for Part A and one for Part B. Part A: Community Education, Awareness, and Capacity Building, and Part B: Professional Education and Training. Strategies and activities conducted under each part may contribute to more people with hepatitis B and hepatitis C able to make informed health decisions and obtain proper care and treatment which can lead to decreased morbidity and mortality from hepatitis B and hepatitis C. Part A strategies and activities focus on 1) leading, maintaining, and growing an existing coalition of public and private organizations serving populations disproportionately affected by hepatitis B and/or hepatitis C, 2) providing technical assistance and training to coalition members to deliver hepatitis B and/or hepatitis C educational outreach to disproportionately affected populations, and 3) building capacity of coalition members to conduct hepatitis B and/or…
Read the full description
In alignment with CDC's viral hepatitis strategic goals and current epidemiology, this Notice of Funding Opportunity (NOFO) will address the need for increasing awareness of viral hepatitis prevention, testing, and treatment options among populations disproportionately affected by hepatitis B and/or hepatitis C virus infections. The priority populations' needs will also be addressed by increasing healthcare professionals' competence in the evaluation and treatment of hepatitis B and/or hepatitis C virus infection. The outcomes of this NOFO will be achieved through two separate components. An organization may apply for one component or both components by submitting two separate applications, one for Part A and one for Part B. Part A: Community Education, Awareness, and Capacity Building, and Part B: Professional Education and Training. Strategies and activities conducted under each part may contribute to more people with hepatitis B and hepatitis C able to make informed health decisions and obtain proper care and treatment which can lead to decreased morbidity and mortality from hepatitis B and hepatitis C. Part A strategies and activities focus on 1) leading, maintaining, and growing an existing coalition of public and private organizations serving populations disproportionately affected by hepatitis B and/or hepatitis C, 2) providing technical assistance and training to coalition members to deliver hepatitis B and/or hepatitis C educational outreach to disproportionately affected populations, and 3) building capacity of coalition members to conduct hepatitis B and/or hepatitis C virus infection testing and linkage to treatment in settings serving disproportionately affected populations. Short-term outcomes include increasing capacity of the coalition to expand services to a larger number of populations disproportionately affected by hepatitis B and hepatitis C, increasing capacity of coalition members to deliver hepatitis B and/or hepatitis C educational outreach to disproportionately affected populations, and increasing testing for hepatitis B and/or hepatitis C virus infection among disproportionately affected populations. Part B strategies and activities focus on 1) providing free comprehensive web-based, accurate, on-demand resources and trainings for healthcare professionals for hepatitis B and hepatitis C, and associated continuing education credits, and 2) actively marketing and promoting training and resources.
Agency contact
Lindsey Sizemore
ocr1@cdc.gov